1
|
Mongereau M, Hua C, Hersant B, Bosc R, Woerther P, Champy C, De Angelis N, Tomberli F, De Prost N, Chosidow O. Fasciites nécrosantes abdomino-périnéales (gangrènes de Fournier) : étude rétrospective monocentrique de 52 patients incluant la recherche d’une porte d’entrée à moyen terme. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.114] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
2
|
Ingels A, Bibas S, Da Costa JB, Attias A, Brunetti F, De Angelis N, Desgranges P, Flouzat-Lachaniette CH, Folliguet T, Ivanov T, Langeron O, Lelde L, Levesque E, Corvoisier PL, Marmorat C, Melendugno F, Meningaud JP, Mesli F, Paillusson W, Palfi S, Pedre L, Somacale D, Champy CM, de la Taille A. Surgery and COVID-19: Balancing the nosocomial risk a french academic center experience during the epidemic peak. Br J Surg 2020; 107:e395-e397. [PMID: 32725815 PMCID: PMC7929147 DOI: 10.1002/bjs.11841] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2020] [Accepted: 06/03/2020] [Indexed: 01/12/2023]
Affiliation(s)
- A Ingels
- Department of Urology, Hôpital Henri Mondor - APHP, UPEC, Créteil, France
| | - S Bibas
- Department of Urology, Hôpital Henri Mondor - APHP, UPEC, Créteil, France
| | - J B Da Costa
- Department of Urology, Hôpital Henri Mondor - APHP, UPEC, Créteil, France
| | - A Attias
- Department of Anesthesiology and Intensive Care, Hôpital Henri Mondor - APHP, UPEC, Créteil, France
| | - F Brunetti
- Department of Visceral surgery, Hôpital Henri Mondor - APHP, UPEC, Créteil, France
| | - N De Angelis
- Department of Visceral surgery, Hôpital Henri Mondor - APHP, UPEC, Créteil, France
| | - P Desgranges
- Department of Vascular surgery, Hôpital Henri Mondor - APHP, UPEC, Créteil, France
| | | | - T Folliguet
- Department of Cardiac surgery, Hôpital Henri Mondor - APHP, UPEC, Créteil, France
| | - T Ivanov
- Department of Visceral surgery, Hôpital Henri Mondor - APHP, UPEC, Créteil, France
| | - O Langeron
- Department of Anesthesiology and Intensive Care, Hôpital Henri Mondor - APHP, UPEC, Créteil, France
| | - L Lelde
- Department of Visceral surgery, Hôpital Henri Mondor - APHP, UPEC, Créteil, France
| | - E Levesque
- Department of Anesthesiology and Intensive Care, Hôpital Henri Mondor - APHP, UPEC, Créteil, France
| | - P L Corvoisier
- INSERM, CIC 1430 - Hôpital Henri Mondor - APHP, UPEC, Créteil, France
| | - C Marmorat
- Department of Urology, Hôpital Henri Mondor - APHP, UPEC, Créteil, France
| | - F Melendugno
- Department of Urology, Hôpital Henri Mondor - APHP, UPEC, Créteil, France
| | - J-P Meningaud
- Department of Reconstructive surgery, Hôpital Henri Mondor - APHP, UPEC, Créteil, France
| | - F Mesli
- Department of Gastroenterology, Hôpital Henri Mondor - APHP, UPEC, Créteil, France
| | - W Paillusson
- Department of Urology, Hôpital Henri Mondor - APHP, UPEC, Créteil, France
| | - S Palfi
- Department of Neurosurgery, Hôpital Henri Mondor - APHP, UPEC, Créteil, France
| | - L Pedre
- Department of Urology, Hôpital Henri Mondor - APHP, UPEC, Créteil, France
| | - D Somacale
- Department of Visceral surgery, Hôpital Henri Mondor - APHP, UPEC, Créteil, France
| | - C M Champy
- Department of Urology, Hôpital Henri Mondor - APHP, UPEC, Créteil, France
| | - A de la Taille
- Department of Urology, Hôpital Henri Mondor - APHP, UPEC, Créteil, France
| |
Collapse
|
3
|
Manceau G, Mege D, Bridoux V, Lakkis Z, Venara A, Voron T, De Angelis N, Ouaissi M, Sielezneff I, Karoui M, Dazza M, Gagnat G, Hamel S, Mallet L, Martre P, Philouze G, Roussel E, Tortajada P, Dumaine AS, Heyd B, Paquette B, Brunetti F, Esposito F, Lizzi V, Michot N, Denost Q, Tresallet C, Tetard O, Regimbeau JM, Sabbagh C, Rivier P, Fayssal E, Collard M, Moszkowicz D, Peschaud F, Etienne JC, loge L, Beyer L, Bege T, Corte H, D'Annunzio E, Humeau M, Issard J, Munoz N, Abba J, Jafar Y, Lacaze L, Sage PY, Susoko L, Trilling B, Arvieux C, Mauvais F, Ulloa‐Severino B, Lefevre JH, Pitel S, Vauchaussade de Chaumont A, Badic B, Blanc B, Bert M, Rat P, Ortega‐Deballon P, Chau A, Dejeante C, Piessen G, Grégoire E, Alfarai A, Cabau M, David A, Kadoche D, Dufour F, Goin G, Goudard Y, Pauleau G, Sockeel P, De la Villeon B, Pautrat K, Eveno C, Brouquet A, Couchard AC, Balbo G, Mabrut JY, Bellinger J, Bertrand M, Aumont A, Duchalais E, Messière AS, Tranchart A, Cazauran JB, Pichot‐Delahaye V, Dubuisson V, Maggiori L, Djawad‐Boumediene B, Fuks D, Kahn X, Huart E, Catheline JM, Lailler G, Baraket O, Baque P, Diaz de Cerio JM, Mariol P, Maes B, Fernoux P, Guillem P, Chatelain E, de Saint Roman C, Fixot K. Thirty-day mortality after emergency surgery for obstructing colon cancer: survey and dedicated score from the French Surgical Association. Colorectal Dis 2019; 21:782-790. [PMID: 30884089 DOI: 10.1111/codi.14614] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/09/2018] [Accepted: 02/27/2019] [Indexed: 02/08/2023]
Abstract
AIM The aim was to define risk factors for postoperative mortality in patients undergoing emergency surgery for obstructing colon cancer (OCC) and to propose a dedicated score. METHOD From 2000 to 2015, 2325 patients were treated for OCC in French surgical centres by members of the French National Surgical Association. A multivariate analysis was performed for variables with P value ≤ 0.20 in the univariate analysis for 30-day mortality. Predictive performance was assessed by the area under the receiver operating characteristic curve. RESULTS A total of 1983 patients were included. Thirty-day postoperative mortality was 7%. Multivariate analysis found five significant independent risk factors: age ≥ 75 (P = 0.013), American Society of Anesthesiologists (ASA) score ≥ III (P = 0.027), pulmonary comorbidity (P = 0.0002), right-sided cancer (P = 0.047) and haemodynamic failure (P < 0.0001). The odds ratio for risk of postoperative death was 3.42 with one factor, 5.80 with two factors, 15.73 with three factors, 29.23 with four factors and 77.25 with five factors. The discriminating capacity in predicting 30-day postoperative mortality was 0.80. CONCLUSION Thirty-day postoperative mortality after emergency surgery for OCC is correlated with age, ASA score, pulmonary comorbidity, site of tumour and haemodynamic failure, with a specific score ranging from 0 to 5.
Collapse
Affiliation(s)
- G Manceau
- Department of Digestive Surgery, Assistance Publique Hôpitaux de Paris, Pitié Salpêtrière Hospital, Sorbonne Université, Paris, France
| | - D Mege
- Department of Digestive Surgery, Timone University Hospital, Marseille, France
| | - V Bridoux
- Department of Digestive Surgery, Charles Nicolle University Hospital, Rouen, France
| | - Z Lakkis
- Department of Digestive Surgery, Besançon University Hospital, Besançon, France
| | - A Venara
- Department of Digestive Surgery, Angers University Hospital, Angers, France
| | - T Voron
- Department of Digestive Surgery, Assistance Publique Hôpitaux de Paris, Saint Antoine Hospital, Sorbonne Université, Paris, France
| | - N De Angelis
- Department of Digestive Surgery, Assistance Publique Hôpitaux de Paris, Henri Mondor Hospital, Université Paris-Est (UEP), Créteil, France
| | - M Ouaissi
- Department of Digestive Surgery, Tours University Hospital, Tours, France
| | - I Sielezneff
- Department of Digestive Surgery, Timone University Hospital, Marseille, France
| | - M Karoui
- Department of Digestive Surgery, Assistance Publique Hôpitaux de Paris, Pitié Salpêtrière Hospital, Sorbonne Université, Paris, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
4
|
Ambroisine ML, Milliez P, Nehme J, Pasquier AL, De Angelis N, Mansier P, Swynghedauw B, Delcayre C. Aldosterone and anti-aldosterone effects in cardiovascular diseases and diabetic nephropathy. Diabetes & Metabolism 2004; 30:311-8. [PMID: 15525873 DOI: 10.1016/s1262-3636(07)70122-2] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Cells in the cortical collecting duct of distal nephron have been considered for a long time as the unique cellular targets of aldosterone. However, it is now clear that other cell types in non-epithelial tissues are also potential targets for aldosterone. The functions that this hormone controls in non-epithelial tissues are still a matter of debate. Clinical and experimental studies have established that aldosterone plays a major role in the pathophysiology of cardiovascular and renal diseases. The aldosterone receptor antagonists spironolactone and eplerenone have demonstrated specific effects not related to their hypotensive properties in hypertension or cardiac diseases. It appears that a key action of these molecules is related to prevention or treatment of end-organ damage. The latter fact, and the recognition of aldosterone escape on long-term treatment of heart failure, diabetic nephropathy and some forms of hypertension with ACE inhibitors, justify the clinical use of aldosterone receptor antagonists provided that kaliemia is controlled. Experimental studies have allowed to draw a still incomplete but comprehensive scheme of aldosterone cardiovascular actions in pathological conditions. When elevated, aldosterone has deleterious effects in blood vessels, in the heart and in kidney, which are secondary to the induction of inflammatory and oxidative processes and necrosis, that induce the increased synthesis of extracellular matrix proteins.
Collapse
|